EFFECT OF CERTOLIZUMAB PEGOL ON SIGNS AND SYMPTOMS IN PATIENTS WITH PSORIATIC ARTHRITIS WITH OR WITHOUT PRIOR ANTI-TNF EXPOSURE: 24-WEEK RESULTS OF A PHASE III DOUBLE-BLIND RANDOMIZED PLACEBO-CONTROLLED STUDY
Author(s):
Mease, P.; Fleischmann, R.; Wollenhaupt, J.; Deodhar, A.; Kielar, D.; Woltering, F.; Stach, C.; Hoepken, B.; Arledge, T.; Heijde, D. van der
